Timothy Morris | CFO |
Maria Fardis | President and CEO |
Friedrich Finckenstein | Chief Medical Officer |
Mark Breidenbach | Oppenheimer |
Biren Amin | Jefferies |
Madhu Kumar | R.W. Baird |
Joe Catanzaro | Piper Jaffray |
Boris Peaker | Cowen |
Good afternoon, and welcome to the Iovance Biotherapeutics Second Quarter 2019 Financial Results Conference Call. All participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that the call is being recorded at the company's request.
Now I would like to turn the call over to Tim Morris, Chief Financial Officer at Iovance.